selected publications
-
Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study.
Journal of the European Academy of Dermatology and Venereology : JEADV.
2020
Academic Article
GET IT
Times cited: 16 -
A new checkpoint against ferroptosis.
Cell research.
2020
Comment
GET IT
Times cited: 7 -
Clinical and dermoscopic features associated with lichen planus-like keratoses that undergo skin biopsy: A single-center, observational study.
The Australasian journal of dermatology.
2018
Academic Article
GET IT
Times cited: 14 -
White paper on microbial anti-cancer therapy and prevention.
Journal for immunotherapy of cancer.
2018
Review
GET IT
Times cited: 85 -
Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients.
Journal of the American Academy of Dermatology.
2017
Academic Article
GET IT
Times cited: 21 -
Combination of imiquimod with cryotherapy in the treatment of penile intraepithelial neoplasia.
2017
GET IT
Times cited: 10 -
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells.
Science immunology.
2017
Academic Article
GET IT
Times cited: 79 -
Binding-pocket and lid-region substitutions render human STING sensitive to the species-specific drug DMXAA.
Cell reports.
2014
Academic Article
GET IT
Times cited: 72 -
Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway.
PLoS pathogens.
2014
Academic Article
GET IT
Times cited: 110 -
Dermoscopic findings in cutaneous metastases.
JAMA dermatology.
2014
Academic Article
GET IT
Times cited: 52 -
A novel role for the apoptosis inhibitor ARC in suppressing TNFα-induced regulated necrosis.
Cell death and differentiation.
2014
Academic Article
GET IT
Times cited: 20 -
Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA.
Cell.
2013
Academic Article
GET IT
Times cited: 381 -
Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain.
PloS one.
2012
Academic Article
GET IT
Times cited: 26 -
Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.
Journal of virology.
2011
Academic Article
GET IT
Times cited: 31 -
Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3.
Journal of virology.
2008
Academic Article
GET IT
Times cited: 40 -
Multiple erythematous eroded patches and papules on the scalp.
2008
GET IT
Times cited: 3 -
Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.
Journal of virology.
2007
Academic Article
GET IT
Times cited: 62 -
Dermoscopic and reflectance confocal microscope findings of trichoepithelioma.
2007
GET IT
Times cited: 49 -
Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.
Journal of virology.
2006
Academic Article
GET IT
Times cited: 46 -
Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells.
The Journal of investigative dermatology.
2003
Academic Article
GET IT
Times cited: 52 -
Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis.
The Journal of clinical investigation.
2003
Academic Article
GET IT
Times cited: 24 -
Vaccinia NPH-I, a DExH-box ATPase, is the energy coupling factor for mRNA transcription termination.
Genes & development.
1998
Academic Article
GET IT
Times cited: 62 -
Elongation properties of vaccinia virus RNA polymerase: pausing, slippage, 3' end addition, and termination site choice.
Biochemistry.
1997
Academic Article
GET IT
Times cited: 12 -
Structure-function analysis of the triphosphatase component of vaccinia virus mRNA capping enzyme.
Journal of virology.
1997
Academic Article
GET IT
Times cited: 37 -
Phylogeny of mRNA capping enzymes.
Proceedings of the National Academy of Sciences of the United States of America.
1997
Academic Article
GET IT
Times cited: 101 -
Transcription termination by vaccinia RNA polymerase entails recognition of specific phosphates in the nascent RNA.
The Journal of biological chemistry.
1997
Academic Article
GET IT
Times cited: 9 -
An ATPase component of the transcription elongation complex is required for factor-dependent transcription termination by vaccinia RNA polymerase.
The Journal of biological chemistry.
1996
Academic Article
GET IT
Times cited: 21 -
Factor-dependent release of nascent RNA by ternary complexes of vaccinia RNA polymerase.
The Journal of biological chemistry.
1996
Academic Article
GET IT
Times cited: 31 -
The D1 and D12 subunits are both essential for the transcription termination factor activity of vaccinia virus capping enzyme.
Journal of virology.
1995
Academic Article
GET IT
Times cited: 37 -
A role for the H4 subunit of vaccinia RNA polymerase in transcription initiation at a viral early promoter.
The Journal of biological chemistry.
1994
Academic Article
GET IT
Times cited: 31